In the hypoxic tumor microenvironment, hypoxia-inducible factor 1 (HIF1) promotes hypoxic glycolysis and angiogenesis by binding to its receptor, which in turn further aggravates hypoxia. This evidence concerns the gene HIF1A and neoplasm.